Oncology
Eurofarma developed the first biosimilar drug in Latin America, Fiprima® (filgrastim), indicated for patients undergoing chemotherapy, acting to increase the body’s defense cells.
BackSua experiência fica melhor com um navegador mais recente.
Você pode fazer o download aqui e atualizar o seu.
Eurofarma developed the first biosimilar drug in Latin America, Fiprima® (filgrastim), indicated for patients undergoing chemotherapy, acting to increase the body’s defense cells.
Back